Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Higham

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Pediatrics|September 1, 1992
Smooth muscle tumors in children with human immunodeficiency virus infectionB U Mueller, K M Butler, M C Higham, et al.
Osteoarthritis and Cartilage|January 6, 2019
Losartan attenuates progression of osteoarthritis in the synovial temporomandibular and knee joints of a chondrodysplasia mouse model through inhibition of TGF-β1 signaling pathwayM Thomas, Z Fronk, A Gross, et al.
Dermatology and Therapy|July 8, 2021
The Proposed PASI-HD Provides More Precise Assessment of Plaque Psoriasis Severity in Anatomical Regions with a Low Area ScoreKim A Papp, Mark G Lebwohl, Leon H Kircik, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 1, 1994
Metabolism and disposition of 14C-granisetron in rat, dog and man after intravenous and oral dosingS E Clarke, N E Austin, J C Bloomer, et al.
Pediatric Dermatology|August 27, 2025
Early Evidence of Safety, Clinical Benefit, and Pharmacokinetics of Roflumilast Cream 0.3% Once Daily for Treatment of Mild or Moderate Plaque Psoriasis in Children Aged 2-11 YearsAdelaide A Hebert, Shireen V Guide, Vlada Groysman, et al.
Environmental Science & Technology|January 30, 2009
Effect of fuel and lube oil sulfur on the performance of a diesel exhaust gas continuously regenerating trapD B Kittelson, W F Watts, J P Johnson, et al.
American Journal of Clinical Dermatology|November 12, 2022
Effect of Roflumilast Cream (ARQ-151) on Itch and Itch-Related Sleep Loss in Adults with Chronic Plaque Psoriasis: Patient-Reported Itch Outcomes of a Phase 2b TrialLinda Stein Gold, Javier Alonso-Llamazares, Zoe D Draelos, et al.
The British Journal of Dermatology|March 9, 2023
Efficacy and safety of roflumilast cream for chronic plaque psoriasis with facial/neck and intertriginous area involvement: a post hoc analysis from a randomized controlled trialZoe D Draelos, David N Adam, H Chih-Ho Hong, et al.
Dermatology and Therapy|October 24, 2025
Roflumilast Cream 0.3% in Patients with Chronic Plaque Psoriasis: Pooled PASI and PASI-HD Results from the DERMIS Phase III TrialsKim A Papp, James Q Del Rosso, Mark G Lebwohl, et al.
Pediatric Dermatology|February 21, 2025
Efficacy and Safety of Once-Daily Roflumilast Cream 0.05% in Pediatric Patients Aged 2-5 Years With Mild-to-Moderate Atopic Dermatitis (INTEGUMENT-PED): A Phase 3 Randomized Controlled TrialLawrence F Eichenfield, Rocco Serrao, Vimal H Prajapati, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Pediatrics|September 1, 1992
Smooth muscle tumors in children with human immunodeficiency virus infectionB U Mueller, K M Butler, M C Higham, et al.
Osteoarthritis and Cartilage|January 6, 2019
Losartan attenuates progression of osteoarthritis in the synovial temporomandibular and knee joints of a chondrodysplasia mouse model through inhibition of TGF-β1 signaling pathwayM Thomas, Z Fronk, A Gross, et al.
Dermatology and Therapy|July 8, 2021
The Proposed PASI-HD Provides More Precise Assessment of Plaque Psoriasis Severity in Anatomical Regions with a Low Area ScoreKim A Papp, Mark G Lebwohl, Leon H Kircik, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 1, 1994
Metabolism and disposition of 14C-granisetron in rat, dog and man after intravenous and oral dosingS E Clarke, N E Austin, J C Bloomer, et al.
Pediatric Dermatology|August 27, 2025
Early Evidence of Safety, Clinical Benefit, and Pharmacokinetics of Roflumilast Cream 0.3% Once Daily for Treatment of Mild or Moderate Plaque Psoriasis in Children Aged 2-11 YearsAdelaide A Hebert, Shireen V Guide, Vlada Groysman, et al.
Environmental Science & Technology|January 30, 2009
Effect of fuel and lube oil sulfur on the performance of a diesel exhaust gas continuously regenerating trapD B Kittelson, W F Watts, J P Johnson, et al.
American Journal of Clinical Dermatology|November 12, 2022
Effect of Roflumilast Cream (ARQ-151) on Itch and Itch-Related Sleep Loss in Adults with Chronic Plaque Psoriasis: Patient-Reported Itch Outcomes of a Phase 2b TrialLinda Stein Gold, Javier Alonso-Llamazares, Zoe D Draelos, et al.
The British Journal of Dermatology|March 9, 2023
Efficacy and safety of roflumilast cream for chronic plaque psoriasis with facial/neck and intertriginous area involvement: a post hoc analysis from a randomized controlled trialZoe D Draelos, David N Adam, H Chih-Ho Hong, et al.
Dermatology and Therapy|October 24, 2025
Roflumilast Cream 0.3% in Patients with Chronic Plaque Psoriasis: Pooled PASI and PASI-HD Results from the DERMIS Phase III TrialsKim A Papp, James Q Del Rosso, Mark G Lebwohl, et al.
Pediatric Dermatology|February 21, 2025
Efficacy and Safety of Once-Daily Roflumilast Cream 0.05% in Pediatric Patients Aged 2-5 Years With Mild-to-Moderate Atopic Dermatitis (INTEGUMENT-PED): A Phase 3 Randomized Controlled TrialLawrence F Eichenfield, Rocco Serrao, Vimal H Prajapati, et al.
Pageof 5